GeneNews (OTCMKTS:GNWSF) Trading 16.7% Higher

GeneNews Ltd (OTCMKTS:GNWSF)’s stock price rose 16.7% on Wednesday . The stock traded as high as $0.07 and last traded at $0.07, approximately 26,000 shares changed hands during trading. An increase of 241% from the average daily volume of 7,634 shares. The stock had previously closed at $0.06.

The company has a fifty day simple moving average of $0.08 and a two-hundred day simple moving average of $0.10.

About GeneNews (OTCMKTS:GNWSF)

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.

Featured Article: What is the LIBOR?

Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.